Novo Nordisk (NYSE: NVO) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Novo Nordisk (NYSE:NVO) is one of the best growth stocks to buy for the next decade. On April 2, Novo Nordisk announced results from the ORION study, which is a population-adjusted indirect treatment comparison/ITC evaluating the efficacy and safety of oral semaglutide 25 mg (Wegovy pill) against orforglipron 36 mg. Data derived from the OASIS 4 and ATTAIN-1 clinical trials indicate that oral semaglutide 25 mg was as ...